New development in the new era - Wecare Probiotics adheres to the technological innovation and leads the development of the industry

In recent years, the consumption trend of probiotic products has been increasing day by day, and the industry development has entered a boom period. According to survey data, the output value of the global probiotic industry is expected to exceed US$77 billion in 2025. Wecare Probiotics has been endeavoring for ten years to deeply explore the field of probiotic strains, focusing on the bottleneck issues in probiotic strain technology and industrialization, and constantly advancing on the road of scientific research and innovation.

Strong R&D capabilities

The expanding production capacity is attributed to the strong R&D strength. The company has established professional probiotics research institutes in Suzhou, Wuhan, and Luohe, including 5 major Wec technology systems, as well as 7 research institutes such as the Probiotic Strain Process Research Institute, Microbial Precision Medicine Research Institute, and Fermented Food Strain Research Institute. There are also 12 major research and development platforms, including a high-activity probiotic fermentation process optimization platform, a high-stability probiotic post-processing preparation process optimization platform, and a high-density and high-stable bacterial strain large-scale intelligent manufacturing platform platform. At present, the company has applied for more than 200 invention patents and published more than 100 scientific research papers in core domestic and foreign journals.

Strong production capacity support

The company continuously invests in production capacity to achieve independent supply of probiotic strain raw materials and become a global leading, professional research, production, application, and intelligent manufacturing base for probiotic strains.

Stable quality assurance

The company has always adhered to quality and technology as its general development line, and built an international inspection and testing system platform with complete functions and advanced equipment. The all-round quality system and platform ensure the high-quality intelligent manufacturing of Wecare Probiotics. The bacterial powder raw materials have passed multiple international certifications such as cGMP, GMP, HACCP, ISO22000, FSSC22000, KOSHER, HALAL, and organic certification with excellent quality. The products comply with the quality standards of China CFDA, US FDA and EU EFSA.

Currently, the probiotics industry has entered a stage of innovation-driven development. In this new era of development, Wecare Probiotics always adheres to quality and technology as its development strategy, strengthens technological innovation-driven and scaled, digitized intelligent manufacturing, promotes clinical evidence-based research and application of probiotic strains, accelerates the development of live probiotic drugs, further promotes industry shelf-life standards for probiotics, builds a new development ecology for the probiotics industry, and provides high-quality probiotic strains and comprehensive application solutions.